Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Celyad Oncology (CYAD)

Celyad Oncology SA
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CYAD
DateTimeSourceHeadlineSymbolCompany
04/04/202406:00Business WireCelyad Oncology publie ses résultats financiers pour l'année 2023 ainsi que les récents évènements marquantsNASDAQ:CYADCelyad Oncology SA
04/04/202406:00Business WireCelyad Oncology Reports Full Year 2023 Financial Results and Recent Business HighlightsNASDAQ:CYADCelyad Oncology SA
08/02/202421:01Business WireCelyad Oncology annonce son intention de mettre fin à ses obligations de déclaration à la SECNASDAQ:CYADCelyad Oncology SA
08/02/202421:01Business WireCelyad Oncology Announces Intention to Terminate SEC Reporting ObligationsNASDAQ:CYADCelyad Oncology SA
17/01/202411:33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYADCelyad Oncology SA
16/01/202421:01Business WireCelyad Oncology Provides Fourth Quarter 2023 Business Update and 2024 OutlookNASDAQ:CYADCelyad Oncology SA
16/01/202421:01Business WireCelyad Oncology fait le point sur les activités du quatrième trimestre 2023 et présente ses perspectives pour 2024NASDAQ:CYADCelyad Oncology SA
21/12/202311:19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYADCelyad Oncology SA
20/12/202321:01Business WireCelyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
20/12/202321:01Business WireCelyad Oncology SA : Publication d’une notification de transparence de Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
15/12/202321:01Business WireCelyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)NASDAQ:CYADCelyad Oncology SA
15/12/202321:01Business WireCelyad Oncology SA : Information relative au Nombre Total de Droits de Vote et d’Actions (Article 15 de la Loi du 2 Mai 2007)NASDAQ:CYADCelyad Oncology SA
04/12/202313:34Business WireCelyad Announces Management ChangeNASDAQ:CYADCelyad Oncology SA
04/12/202313:34Business WireCelyad annonce un changement de directionNASDAQ:CYADCelyad Oncology SA
30/11/202321:01Business WireCelyad Oncology SA : Publication d’une notification de transparence reçue de Tolefi SA (Article 14 §1 de la loi du 2 mai 2007)NASDAQ:CYADCelyad Oncology SA
30/11/202321:01Business WireCelyad Oncology SA: Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)NASDAQ:CYADCelyad Oncology SA
21/11/202321:00Business WireCelyad Oncology SA : Publication d’une notification de transparence de Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
21/11/202321:00Business WireCelyad Oncology SA: Publication of a transparency notification received from Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
15/11/202321:37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYADCelyad Oncology SA
14/11/202321:00Business WireCelyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)NASDAQ:CYADCelyad Oncology SA
14/11/202321:00Business WireCelyad Oncology SA : Information relative au Nombre Total de Droits de Vote et d’Actions (Article 15 de la Loi du 2 Mai 2007)NASDAQ:CYADCelyad Oncology SA
09/11/202306:00Business WireCelyad Oncology publie ses résultats financiers pour le troisième trimestre de 2023 ainsi que ses récentes avancéesNASDAQ:CYADCelyad Oncology SA
09/11/202306:00Business WireCelyad Oncology reports third quarter 2023 financial results and recent business highlightsNASDAQ:CYADCelyad Oncology SA
27/10/202318:45Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYADCelyad Oncology SA
25/09/202321:01Business WireCelyad Oncology Announces the Termination of Its American Depository Receipt ProgramNASDAQ:CYADCelyad Oncology SA
25/09/202321:01Business WireCelyad Oncology annonce l’arrêt de son programme d’American Depositary ReceiptNASDAQ:CYADCelyad Oncology SA
18/09/202311:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYADCelyad Oncology SA
15/09/202321:01Business WireCelyad Oncology SA : Publication d’une notification de transparence rectifiée de Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
15/09/202321:01Business WireCelyad Oncology SA: Publication of a Rectified Transparency Notification Received From Fortress Investment Group LLCNASDAQ:CYADCelyad Oncology SA
13/09/202311:29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CYADCelyad Oncology SA
 Showing the most relevant articles for your search:NASDAQ:CYAD